Erkan Çelik

Erkan Çelik

Auto-generated profile, based on publicly available information

Erkan Çelik

Department of Ophthalmology, Sakarya Dünyagöz Hospital, Sakarya, Turkey

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
ECErkan Celik
Erkan Celik
BÇBurçin çakır
Burçin çakır
ETElif Betul Turkoglu
Elif Betul Turkoglu
EDEmine Doğan
Emine Doğan
GAGursoy Alagoz
Gursoy Alagoz

1 November 2016 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
ECErkan Celik
Erkan Celik
BCBurcin Cakir
Burcin Cakir
ETElif Betul Turkoglu
Elif Betul Turkoglu
EDEmine Dogan
Emine Dogan
GAGursoy Alagoz
Gursoy Alagoz
Purpose: We aimed to evaluate the effect of cataract surgery on subfoveal choroidal thickness (CT) and ganglion cell complex (GCC) thickness, as measured by enhanced depth imaging-optical coherence tomography (OCT). Methods: This prospective study included 30 eyes of 30 patients who had undergone uneventful phacoemulsification surgery for senile cataract but had no previous ocular surgery or other ocular abnormality. Best-corrected visual acuity, slit-lamp biomicroscopy, intraocular pressure, axial length, and central corneal thickness were measured preoperatively. The operative times (OTs) and effective phaco times were also recorded in each case. OCT measurements were performed at the preoperative visit and 1 month after cataract surgery. Study of CT and GCC thickness changes was the primary objective, but central macular thickness (CMT) and peripapillary retinal nerve fiber layer (RNFL) thicknesses were also obtained by OCT. Results: The mean subfoveal CT was 294.4±39.2 µm preoperatively and 301.4±39.9 µm postoperatively (P<0.001). The mean GCC thickness was 85.0±4.4 µm preoperatively and 89.2±5.3 µm postoperatively (P<0.001). The mean CMT was 247.9±17.6 µm preoperatively and 249.0±17.8 µm postoperatively (P=0.029). The mean RNFL thickness was 97.4±5.4 µm preoperatively and 101.7±5.6 µm postoperatively (P<0.001). Regression analysis showed that age, sex, axial length, central corneal thickness, operative time, and effective phaco time were not associated with CT changes (P=0.834, P=0.129, P=0.203, P=0.343, P=0.547, and P=0.147, respectively) and GCC thickness changes (P=0.645, P=0.542, P=0.152, P=0.664, P=0.448, and P=0.268, respectively) after cataract surgery. Conclusion: Our results indicate that all subfoveal CT, CMT, as well as RNFL and GCC thicknesses are slightly affected after uneventful phacoemulsification surgery. After cataract surgery, the examiners should consider obtaining new baseline measurements.

1 May 2018 in Journal Français d'Ophtalmologie
Verified
Journal Article
Closed access
BÇBurçin çakır
Burçin çakır
EDE. Doğan
E. Doğan
EÇE. Çelik
E. Çelik
TBT. Babashli
T. Babashli
TUTurgay Ucak
Turgay Ucak
GAG. Alagöz
G. Alagöz

1 December 2015 in Journal Français d'Ophtalmologie
Verified
Journal Article
Closed access
ECE. Celik
E. Celik
BKB. Koklu
B. Koklu
EDE. Dogan
E. Dogan
GEG. Erdogan
G. Erdogan
GAG. Alagoz
G. Alagoz

19 February 2020 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
BÇBurçin çakır
Burçin çakır
NANilgün Özkan Aksoy
Nilgün Özkan Aksoy
SÖSedat Özmen
Sedat Özmen
ÖBÖzlem Bursalı
Özlem Bursalı
EÇErkan Çelik
Erkan Çelik
FHFatih Horozoğlu
Fatih Horozoğlu

21 December 2023 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
UYUğur Yayla
Uğur Yayla
MSMehmet Orkun Sevik
Mehmet Orkun Sevik
VKVeysel Levent Karabaş
Veysel Levent Karabaş
ÖŞÖzlem Şahin
Özlem Şahin
AOAbdullah Ozkaya
Abdullah Ozkaya
EÇErkan Çelik
Erkan Çelik
This study aimed to report the demographic and clinical characteristics of diabetic macular edema (DME) patients treated with intravitreal injection (IVI) of anti-vascular endothelial growth factors (anti-VEGF) and provide an overview of outcomes during routine clinical practice in Türkiye. This retrospective, real-world study included 1,372 eyes (854 patients) treated with a pro re nata protocol by 21 ophthalmologists from 8 tertiary clinics on the Asian side of the Marmara region of Türkiye (MARMASIA Study Group). Five cohort groups were established by collecting the patients' baseline and 3, 6, 12, 24, and 36-month follow-up data, where each subsequent cohort may include the previous. Changes in best-corrected visual acuity (BCVA, approximate ETDRS letters) and central macular thickness (CMT, μm), number of visits and IVI, and rates of anti-VEGF switch and intravitreal dexamethasone implant (IDI) combination were evaluated. The 3, 6, 12, 24, and 36-month cohorts included 1372 (854), 1352 (838), 1185 (722), 972 (581), and 623 (361) eyes (patients), respectively. The mean baseline BCVA and CMT were 51.4±21.4 letters and 482.6±180.3 μm. The mean changes from baseline in BCVA were +7.6, +9.1, +8.0, +8.6, and +8.4 letters, and in CMT were -115.4, -140.0, -147.9, -167.3, and -215.4 μm at the 3, 6, 12, 24, and 36-month visits (p<0.001 for all). The median cumulative number of anti-VEGF IVI was 3.0, 3.0, 5.0, 7.0, and 9.0, respectively. The overall anti-VEGF switch and IDI combination rates were 18.5% (253/1372 eyes) and 35.0% (480/1372 eyes), respectively. This largest real-life study of DME from Türkiye demonstrated BCVA gains inferior to randomized controlled trials, mainly due to the lower number of IVI. However, with the lower baseline BCVA and higher IDI combination rates in our cohorts, these gains were relatively superior to other real-life study counterparts.